Here is an interesting BBC news story regarding the current state of drug treatment for Alzheimer’s disease.
It aligns well with my own views, referring to my discussions with pharmaceutical company representatives at the AAIC event in Toronto last July. Based on this, there is plenty of room and a clear need for the development of neuromodulation treatments in the form of the collaboration between Nexstim and Sinaptica.